retatrutide diabetes type 2 Phase 2: Weight Loss and Key Trial Findings – Bolt Pharmacy The Effect of Retatrutide on
Description
Un estudio reciente publicado en Nature Metabolism mostr que suplementar con almidn resistente durante ocho semanas ayud a lograr prdida de peso (2.8 kg en promedio) y mejor la resistencia a la insulina en personas con exceso de peso, con beneficios asociados a cambios en la composicin del microbiota intestinal

#pharmacy #pharmacist #personalizedmedicine #innovation #storytelling #healthtech #thepharmacistsarein To view or add a comment, sign in 4,183 followers
GLP-1 Game-Changer: How Oral GLP-1s Will Shape Health Plan Strategy Authored by Leslie Lotano-Saba GLP-1s for diabetes and obesity are already a top concern of health plan CEOs, with the category forecasted to achieve 13% to 15% CAGR growth from 2024 to 2034, reaching approximately $130 billion in total market size

What's Included Online health assessment Clinician-guided GLP-1 treatments Free shipping to your door No waiting rooms

I'd much rather see a slower, careful approval process than another medication rushed into widespread use without enough guardrails." Why Retatrutide May Not Be the Answer for Everyone Kenner also raises broader concerns about how weight-loss drugs are being framed culturally

The current administrations reluctance to expand Medicare coverage (Apr 2025) demonstrates political pushback on broad coverage